Defining iron replete status in patients with heart failure treated with intravenous iron

Published: December 21, 2023
Abstract Views: 1733
pdf: 52
HTML: 3
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Iron deficiency is an important therapeutic target in patients with heart failure and reduced ejection fraction (HFrEF). Over the past two decades, several trials of intravenous (IV) iron supplementation in HFrEF have shown favorable effects on symptoms, functional status, and heart failure (HF) hospitalizations...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Talha, K. M., Butler, J., von Haehling, S., Lainscak, M., Ponikowski, P., & Anker, S. D. (2023). Defining iron replete status in patients with heart failure treated with intravenous iron. Global Cardiology, 1(1). https://doi.org/10.4081/cardio.2023.17